Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 and up

Using tesamorelin to help recovery after nerve injuries

Official title: Tesamorelin Therapy to Enhance Axonal Regeneration, Minimize Muscle Atrophy, and Improve Functional Outcomes Following Peripheral Nerve Injury

Run by Johns Hopkins University · NCT03150511 · Data updated 2026-11-12

This study is testing if a medication called tesamorelin can help people recover better after surgery for nerve injuries, specifically those affecting the ulnar nerve.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment36 (estimated)
SponsorJohns Hopkins University
Academic / other
Locations1 site (Baltimore, Maryland)
StatusRecruiting
StartedJune 1, 2018
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedNovember 9, 2026
Trial IDNCT03150511 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals with repaired ulnar nerve lacerations at the wrist.

Probably not a fit

Patients with certain cancers, uncontrolled diabetes or hypertension, or other specified health issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of tesamorelin in improving recovery outcomes for patients with peripheral nerve injuries, specifically focusing on ulnar nerve lacerations. Participants will be randomly assigned to receive either tesamorelin or no treatment after surgical repair of their nerve injury. The study will assess recovery through clinical exams, electrodiagnostic studies, and questionnaires over a 12-month period. The goal is to determine if tesamorelin can enhance nerve regeneration and functional recovery compared to the untreated group.

Why it matters

Potential benefit: If successful, this treatment could lead to faster and more effective recovery of motor and sensory functions for patients with peripheral nerve injuries.

How similar studies have gone: While the use of tesamorelin for nerve injuries is a novel approach, previous studies have shown growth hormone's potential to improve nerve regeneration in animal models.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Ulnar nerve laceration at the wrist, repaired primarily

Exclusion Criteria:

* Certain cancers (active or in the past)
* Uncontrolled diabetes or hypertension
* Certain pituitary problems
* Oral contraceptives
* Pregnancy
* Drug or alcohol dependence
* Psychosocial issues that would limit participation and compliance

Where it's running

  • Sami Tuffaha
    Baltimore, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Sami Tuffaha, MD — Johns Hopkins University
  • Study coordinator: Sami Tuffaha, MD
  • Email: stuffah1@jhmi.edu
  • Phone: 410-614-4333

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.